AbbVie Inc. (ABBV) Return on equity 2016–2024
AbbVie Inc. (ABBV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
128.7%FY2024 · since FY2016: 128.4% → 128.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 128.7% | +81.7 pp |
| FY2023 | 46.9% | -21.7 pp |
| FY2022 | 68.6% | -6.3 pp |
| FY2021 | 74.9% | +39.6 pp |
| FY2020 | 35.3% | — |
| FY2017 | 104.2% | -24.2 pp |
| FY2016 | 128.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net incomeABBV Net marginABBV Gross profitABBV Gross marginABBV Operating incomeABBV Operating marginABBV Operating cash flowABBV Free cash flowABBV Capital expendituresABBV Stock buybacksABBV Dividends paidABBV Total assetsABBV Total liabilitiesABBV Shareholders’ equityABBV overview →